BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Sudarshan Chemical Industries’ (SCIL) Q4FY23 print showed early signs of demand revival across categories. SCIL sees tailwinds from recovery in demand; it is receiving good response for its new products, which are niche chemistries; ramp up in new capacity to provide pigment segment revenue visibility of Rs30-33bn and softening raw material prices will help normalise margins. SCIL has already started its margin-recovery journey, and expects further improvement in next few quarters as inflation in other expenses drop.
We believe the company has remarkably worked on improving its balance sheet which will benefit from proceeds of land sales (Rs3.6bn) and stable net working capital at 20% of sales (down from 24-25%). We expect net debt / EBITDA to dip to ~1x by FY24. We have raised our adjusted EPS estimates by 4- 14% over FY24-25, and accordingly, increased target price to Rs550 (from Rs405), valuing the company at 18x FY25E EPS (prior: 15x). We upgrade the stock to BUY (from Add). Key risks: Major softness in demand, and slower margin recovery.
Click on the attachment to read the full report:
Disclaimer
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
TCI Express Q1 Results Review - Low Volumes Result In Subdued Performance: ICICI Securities
Aug 14, 2024
Genus Power Q1 Results Review - Strong Start To FY25: ICICI Securities
Aug 06, 2024
Titan Q1 Result Review: Analysts See International Segment, Jewellery Leading Growth
Aug 05, 2024
Clean Science Q1 Review - Inline Result Led By Volume Recovery: Nirmal Bang
Aug 02, 2024
POPULAR